- Home
- TCRX vs TOUR Comparison
TCRX vs TOUR Comparison
Compare TCRX & TOUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- TOUR
- Stock Information
- Founded
- TCRX 2018
- TOUR 2006
- Country
- TCRX United States
- TOUR China
- Employees
- TCRX N/A
- TOUR N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- TOUR Transportation Services
- Sector
- TCRX Health Care
- TOUR Consumer Discretionary
- Exchange
- TCRX Nasdaq
- TOUR Nasdaq
- Market Cap
- TCRX 90.5M
- TOUR 101.0M
- IPO Year
- TCRX 2021
- TOUR 2014
- Fundamental
- Price
- TCRX $1.27
- TOUR $0.94
- Analyst Decision
- TCRX Strong Buy
- TOUR
- Analyst Count
- TCRX 7
- TOUR 0
- Target Price
- TCRX $9.86
- TOUR N/A
- AVG Volume (30 Days)
- TCRX 389.5K
- TOUR 87.9K
- Earning Date
- TCRX 05-06-2025
- TOUR 06-03-2025
- Dividend Yield
- TCRX N/A
- TOUR 3.76%
- EPS Growth
- TCRX N/A
- TOUR N/A
- EPS
- TCRX N/A
- TOUR 0.09
- Revenue
- TCRX $4,421,000.00
- TOUR $70,367,853.00
- Revenue This Year
- TCRX $47.30
- TOUR $16.99
- Revenue Next Year
- TCRX $74.30
- TOUR $13.23
- P/E Ratio
- TCRX N/A
- TOUR $11.09
- Revenue Growth
- TCRX N/A
- TOUR 16.40
- 52 Week Low
- TCRX $1.02
- TOUR $0.71
- 52 Week High
- TCRX $9.69
- TOUR $1.76
- Technical
- Relative Strength Index (RSI)
- TCRX 37.62
- TOUR 50.18
- Support Level
- TCRX $1.32
- TOUR $0.90
- Resistance Level
- TCRX $1.65
- TOUR $0.98
- Average True Range (ATR)
- TCRX 0.12
- TOUR 0.04
- MACD
- TCRX -0.02
- TOUR 0.01
- Stochastic Oscillator
- TCRX 0.00
- TOUR 63.55
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About TOUR Tuniu Corporation
Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.